TRIM28 and cancer: These findings lay a foundation for further investigations of the role of the SMURF2–KAP1 axis in the carcinogenic process and therapeutic response, with an ultimate goal to develop new, more effective treatment strategies based on the disruption in cancers of the dysregulated SMURF2/KAP1 module.